Authors: Bell, IM Gallicchio, SN Abrams, M Beshore, DC Buser, CA Culberson, JC Davide, J Ellis-Hutchings, M Fernandes, C Gibbs, JB Graham, SL Hartman, GD Heimbrook, DC Homnick, CF Huff, JR Kassahun, K Koblan, KS Kohl, NE Lobell, RB Lynch, JJ Miller, PA Omer, CA Rodrigues, AD Walsh, ES Williams, TM

Citation: Im. Bell et al., Design and biological activity of (S)-4-(5-{[1-(3-chlorobenzyl)-2-oxopyrrolidin-3-ylamino]methyl}imidazol-1-ylmethyl)benzonitrile, a 3-aminopyrrolidinone farnesyltransferase inhibitor with excellent cell potency, J MED CHEM, 44(18), 2001, pp. 2933-2949

Authors: Bell, IM Beshore, DC Gallicchio, SN Williams, TM

Citation: Im. Bell et al., Efficient synthesis of 1-heterocyclic-3-aminopyrrolidinones, TETRAHEDR L, 41(8), 2000, pp. 1141-1145

Authors: Williams, PD Bock, MG Evans, BE Freidinger, RM Gallicchio, SN Guidotti, MT Jacobson, MA Kuo, MS Levy, MR Lis, EV Michelson, SR Pawluczyk, JM Perlow, DS Pettibone, DJ Quigley, AG Reiss, DR Salvatore, C Stauffer, KJ Woyden, CJ

Citation: Pd. Williams et al., Nonpeptide oxytocin antagonists: Analogs of L-371,257 with improved potency, BIOORG MED, 9(9), 1999, pp. 1311-1316